Dr. Eric Johnson is an accomplished and pioneering researcher with over 40 years of experience in toxicology and microbiology, primarily focused on work in pharmaceuticals and biotechnology. He is renowned for his leadership at the University of Wisconsin-Madison, where he served as a Professor and Lab Director of the Botulinum Toxins Laboratory and contributed significantly to the fields of food microbiology, toxicology, and bacteriology

Dr. Johnson's career is highlighted by his role in spearheading the purification of botulinum toxin in collaboration with Dr. Ed Schantz, leading to the first FDA-approved batches of Botox. This discovery marked a major milestone in therapeutic and cosmetic applications of botulinum toxin.

With a rich foundation in education, holding a Doctorate in Biotechnology from MIT and postdoctoral training at Harvard, Dr. Johnson has founded and led two companies, holds over 30 patents, and has authored more than 250 journal publications and nearly 70 book chapters. Since transitioning solely to consulting in 2021, he has continued to leverage his expertise to advise on complex issues in toxicology and microbiology, aiming to drive innovation and impact in the botulinum field.

Recognized for his contributions with numerous awards and patents, Dr. Johnson brings a wealth of knowledge, a track record of innovation, and a dedication to advancing research and development.